Telehealth and Virtual Medical Services in the US

Telehealth has moved from a niche workaround to a core delivery channel for US medical services — one that now touches everything from routine primary care to psychiatric prescribing. This page covers how telehealth is defined, structured, and regulated at the federal and state levels; what drives its adoption and limits; and where the real tensions lie between convenience, safety, and coverage. It also addresses persistent misconceptions about what virtual care actually can and cannot do.

• Definition and scope
• Core mechanics or structure
• Causal relationships or drivers
• Classification boundaries
• Tradeoffs and tensions
• Common misconceptions
• Checklist or steps (non-advisory)
• Reference table or matrix

Definition and scope

The Health Resources and Services Administration (HRSA) defines telehealth as the use of electronic information and telecommunications technologies to support long-distance clinical health care, patient and professional health-related education, public health, and health administration. That's a deliberately wide net — wide enough to include a video psychiatric appointment in Montana, a remote blood pressure monitor feeding data to a cardiologist's dashboard in Cleveland, and a pharmacist conducting a medication review by phone in rural Mississippi.

The federal government draws a distinction between telehealth (the broad category) and telemedicine (clinical care specifically). The Centers for Medicare & Medicaid Services (CMS) uses "telehealth" in its statutory language, while many state medical boards use "telemedicine" in licensure rules. Both terms appear throughout insurance contracts and clinical policy documents, often interchangeably — which creates its own category of administrative headache.

The scope of US telehealth services now spans all 50 states and spans mental health services, primary care, dermatology, endocrinology, infectious disease, and chronic disease management. It intersects deeply with questions of regulatory context for medical services, particularly around licensure, prescribing authority, and privacy standards under HIPAA.

Core mechanics or structure

Telehealth operates across three primary delivery modes, each with distinct technical and regulatory footprints.

Synchronous (live video). A real-time audiovisual encounter between patient and clinician. This is the dominant model for most clinical telehealth — it most closely mirrors an in-person visit and is the mode CMS recognizes for the broadest range of reimbursable services. Platforms must comply with the HIPAA Security Rule (45 CFR Part 164), which mandates encryption, access controls, and audit logging.

Asynchronous (store-and-forward). Clinical information — images, lab results, patient-submitted video — is collected and transmitted to a provider for review at a later time. Common in dermatology, radiology, and ophthalmology. The provider does not interact with the patient in real time. CMS covers store-and-forward telehealth for Alaska and Hawaii under specific demonstration programs, though federal coverage for this modality is otherwise limited.

Remote Patient Monitoring (RPM). Connected devices — glucometers, pulse oximeters, blood pressure cuffs — transmit physiological data from the patient's home to a clinical team. CMS added RPM billing codes (CPT codes 99453, 99454, 99457, and 99458) as covered services, a move that formalized RPM as a billable care management tool rather than a research-only concept.

The technical backbone of telehealth — electronic health record integration, prescription transmission, secure messaging — sits within the broader technology innovation in medical services ecosystem and increasingly connects to interoperability mandates under the 21st Century Cures Act.

Causal relationships or drivers

Three forces have shaped telehealth's expansion, and they don't all point in the same direction.

Emergency regulatory waivers. The COVID-19 public health emergency (PHE) is the largest single driver of telehealth expansion in US history. CMS waived the "originating site" requirement — the rule that previously restricted Medicare telehealth to patients in rural, federally designated shortage areas. During the PHE, patients could receive telehealth from home. Congress extended these waivers through December 31, 2024 (Consolidated Appropriations Act, 2023, Pub. L. 117-328). The permanence of those flexibilities beyond that date remains a contested policy question as of the most recent legislative session.

Geographic and access gaps. The Federal Office of Rural Health Policy documents that rural communities face persistent shortages of specialists, primary care physicians, and behavioral health providers. Telehealth is functionally the only scalable mechanism to extend specialist access to the roughly 20 percent of the US population living in rural areas (US Census Bureau).

Payer behavior. As of 2023, all 50 states plus the District of Columbia have enacted some form of private insurance coverage mandate for telehealth services, though the scope of those mandates varies considerably by state. The National Conference of State Legislatures (NCSL) tracks these state-by-state variations, which include coverage parity laws, audio-only service requirements, and reimbursement rate rules.

Classification boundaries

Telehealth services are not a monolithic category. The distinctions matter for coverage, prescribing, and licensing.

Federally Qualified Health Centers (FQHCs) and Rural Health Clinics (RHCs) operate under specific telehealth rules distinct from private practice settings. CMS expanded their ability to serve as distant sites (where the provider is located) during the PHE, a change that altered how medical services for rural communities are structured in practice.

Mental health telehealth carries a distinct regulatory subset. The DEA's 2023 proposed rules on telemedicine prescribing of controlled substances — triggered by the expiration of PHE-era flexibilities — drew over 38,000 public comments, according to the DEA's own rulemaking docket. Prescribing Schedule II-V substances via telemedicine without a prior in-person visit remains one of the most contested classification questions in US telehealth policy.

Audio-only telehealth (telephone without video) is treated differently from video by most payers. CMS covers audio-only visits under specific CPT codes, but at lower rates than video encounters. State Medicaid programs vary sharply on whether audio-only qualifies for parity reimbursement.

Tradeoffs and tensions

The convenience case for telehealth is easy to make. The complications are harder to see from a waiting room.

Licensure friction. Physicians must generally hold a license in the state where the patient is located, not where the provider practices. The Interstate Medical Licensure Compact (IMLC), administered by the Federation of State Medical Boards (FSMB), operates across 39 participating states and territories as of 2024, streamlining multi-state licensure — but 11 states remain outside it. A psychiatrist licensed in New York who wants to treat a patient in a non-compact state faces a separate, full licensure process.

Equity paradox. Telehealth can reduce geographic barriers while simultaneously deepening digital ones. Patients without broadband access, smartphones, or digital literacy — disproportionately low-income, elderly, or rural — may face greater exclusion from video-based care than from traditional in-person care. This tension surfaces in coverage discussions around medical services for seniors and medical services for low-income individuals.

Diagnostic limits. Physical examination, auscultation, palpation — the tactile core of clinical assessment — cannot be replicated via video. The question of what is safe to diagnose and treat remotely is not fully settled, and the answer varies significantly by specialty and patient population.

Common misconceptions

Misconception: Telehealth is always covered if an in-person visit would be covered. This is false. Parity laws exist in all 50 states, but "parity" in most statutes means coverage cannot be denied solely because the service is delivered via telehealth — not that reimbursement rates must be equal or that all services covered in person are automatically covered virtually.

Misconception: Telehealth operates outside HIPAA. Virtual care platforms are subject to the full HIPAA Privacy and Security Rules (45 CFR Parts 160 and 164). The HHS Office for Civil Rights (OCR) has issued specific guidance on the use of remote communication technologies in healthcare.

Misconception: Any physician can prescribe via telehealth in any state. Prescribing authority via telehealth is subject to both state medical board rules and federal controlled substance law. The Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. § 831) requires, with certain exceptions, an in-person medical evaluation before prescribing controlled substances, and DEA enforcement of those requirements resumed active scrutiny after PHE flexibilities narrowed.

Misconception: Store-and-forward is universally covered. CMS covers store-and-forward only in limited circumstances. Most commercial payers' policies on asynchronous telehealth are inconsistent and often exclude it or require prior authorization. The prior authorization landscape for medical services adds another layer to this.

Checklist or steps (non-advisory)

Steps involved in establishing a telehealth encounter (structural overview)

1. Verify patient location — the state where the patient is physically located at the time of the visit governs licensure requirements.
2. Confirm provider licensure in that state, or verify IMLC participation if applicable.
3. Select a HIPAA-compliant platform — the HHS Office for Civil Rights maintains guidance on acceptable remote communication technologies.
4. Obtain and document informed consent — most state medical boards require explicit consent for telehealth delivery, documented in the medical record.
5. Confirm payer coverage and modality — verify whether the specific modality (video, audio-only, asynchronous) is covered under the patient's plan.
6. Document the encounter as required by the applicable CPT or HCPCS billing codes, including time, modality, and clinical decision-making level.
7. Transmit prescriptions through state-compliant electronic prescribing systems; controlled substance rules require separate verification under DEA regulations.
8. Coordinate follow-up — determine whether subsequent care will remain virtual or require in-person evaluation based on clinical findings.

Reference table or matrix

Telehealth Modality Comparison: Key Dimensions

The full medical services overview provides broader context on how telehealth intersects with inpatient, outpatient, and ambulatory care models across the US health system.